Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Sulphonamides
Revenue, means the sales value of Sulphonamides
This report studies Sulphonamides in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
Abbott Laboratories
Boehringer Ingelheim Pharmaceuticals
Bayer AG
GlaxoSmithKline
King Pharmaceuticals
Mylan Pharmaceuticals
Novartis International AG
Pfizer
Par Pharmaceutical
Roche Holding AG
Sanofi Aventis
Stiefel Laboratories
Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Orally Absorbable Sulfonamide
Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
Split by Application, this report focuses on consumption, market share and growth rate of Sulphonamides in each application, can be divided into
Skin Infections
Gastro Intestinal Tract (GIT) Infection
Meningitis
China Sulphonamides Market Research Report 2017
1 Sulphonamides Market Overview
1.1 Product Overview and Scope of Sulphonamides
1.2 Sulphonamides Segment by Type
1.2.1 China Production Market Share of Sulphonamides Type in 2015
1.2.2 Orally Absorbable Sulfonamide
1.2.3 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
1.2.4 Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
1.3 Applications of Sulphonamides
1.3.1 Sulphonamides Consumption Market Share by Application in 2015
1.3.2 Skin Infections
1.3.3 Gastro Intestinal Tract (GIT) Infection
1.3.4 Meningitis
1.4 China Market Size (Value) of Sulphonamides (2012-2022)
1.5 China Sulphonamides Status and Outlook
1.6 Government Policies
2 China Sulphonamides Market Competition by Manufacturers
2.1 China Sulphonamides Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Sulphonamides Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Sulphonamides Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Sulphonamides Manufacturing Base Distribution, Sales Area, Product Type
2.5 Sulphonamides Market Competitive Situation and Trends
2.5.1 Sulphonamides Market Concentration Rate
2.5.2 Sulphonamides Market Share of Top 3 and Top 5 Manufacturers
3 China Sulphonamides Manufacturers Profiles/Analysis
3.1 Abbott Laboratories
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Sulphonamides Product Type, Application and Specification
3.1.2.1 Orally Absorbable Sulfonamide
3.1.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
3.1.3 Abbott Laboratories Sulphonamides Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 Boehringer Ingelheim Pharmaceuticals
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Sulphonamides Product Type, Application and Specification
3.2.2.1 Orally Absorbable Sulfonamide
3.2.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
3.2.3 Boehringer Ingelheim Pharmaceuticals 120 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 Bayer AG
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Sulphonamides Product Type, Application and Specification
3.3.2.1 Orally Absorbable Sulfonamide
3.3.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
3.3.3 Bayer AG 127 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 GlaxoSmithKline
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Sulphonamides Product Type, Application and Specification
3.4.2.1 Orally Absorbable Sulfonamide
3.4.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
3.4.3 GlaxoSmithKline Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 King Pharmaceuticals
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Sulphonamides Product Type, Application and Specification
3.5.2.1 Orally Absorbable Sulfonamide
3.5.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
3.5.3 King Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 Mylan Pharmaceuticals
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Sulphonamides Product Type, Application and Specification
3.6.2.1 Orally Absorbable Sulfonamide
3.6.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
3.6.3 Mylan Pharmaceuticals Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 Novartis International AG
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Sulphonamides Product Type, Application and Specification
3.7.2.1 Orally Absorbable Sulfonamide
3.7.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
3.7.3 Novartis International AG Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 Pfizer
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Sulphonamides Product Type, Application and Specification
3.8.2.1 Orally Absorbable Sulfonamide
3.8.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
3.8.3 Pfizer Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
3.9 Par Pharmaceutical
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Sulphonamides Product Type, Application and Specification
3.9.2.1 Orally Absorbable Sulfonamide
3.9.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
3.9.3 Par Pharmaceutical Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.9.4 Main Business/Business Overview
3.10 Roche Holding AG
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Sulphonamides Product Type, Application and Specification
3.10.2.1 Orally Absorbable Sulfonamide
3.10.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
3.10.3 Roche Holding AG Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.10.4 Main Business/Business Overview
3.11 Sanofi Aventis
3.12 Stiefel Laboratories
4 China Sulphonamides Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
4.1 China Sulphonamides Capacity, Production and Growth (2012-2017)
4.2 China Sulphonamides Revenue and Growth (2012-2017)
4.3 China Sulphonamides Production, Consumption, Export and Import (2012-2017)
5 China Sulphonamides Production, Revenue (Value), Price Trend by Type
5.1 China Sulphonamides Production and Market Share by Type (2012-2017)
5.2 China Sulphonamides Revenue and Market Share by Type (2012-2017)
5.3 China Sulphonamides Price by Type (2012-2017)
5.4 China Sulphonamides Production Growth by Type (2012-2017)
6 China Sulphonamides Market Analysis by Application
6.1 China Sulphonamides Consumption and Market Share by Application (2012-2017)
6.2 China Sulphonamides Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries
7 ChinaSulphonamides Market Analysis by Regions (Provinces)
7.1 China Sulphonamides Production, Production Value and Price by Regions (Provinces)(2012-2017)
7.1.1 China Sulphonamides Production and Market Share by Regions (Provinces)(2012-2017)
7.1.2 China Sulphonamides Production Value and Market Share by Regions (Provinces)(2012-2017)
7.1.3 China Sulphonamides Sales Price by Regions (Provinces)(2012-2017)
7.2 China Sulphonamides Consumption by Regions (Provinces)(2012-2017)
7.3 China Sulphonamides Production, Consumption, Export and Import (2012-2017)
8 Sulphonamides Manufacturing Cost Analysis
8.1 Sulphonamides Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Sulphonamides
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Sulphonamides Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Sulphonamides Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 China Sulphonamides Market Forecast (2017-2022)
12.1 China Sulphonamides Capacity, Production, Revenue Forecast (2017-2022)
12.2 China Sulphonamides Production, Import, Export and Consumption Forecast (2017-2022)
12.3 China Sulphonamides Production Forecast by Type (2017-2022)
12.4 China Sulphonamides Consumption Forecast by Application (2017-2022)
12.5 China Sulphonamides Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.5.1 China Sulphonamides Production Forecast by Regions (Provinces)(2017-2022)
12.5.2 China Sulphonamides Consumption Forecast by Regions (Provinces)(2017-2022)
12.5.3 China Sulphonamides Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.6 Sulphonamides Price Forecast (2017-2022)
13 Research Findings and Conclusion
14 Appendix
Methodology
Analyst Introduction
Data Source
Figure Picture of Sulphonamides
Figure China Production Market Share of Sulphonamides by Type in 2015
Figure Product Picture of Orally Absorbable Sulfonamide
Table Major Manufacturers of Orally Absorbable Sulfonamide
Figure Product Picture of Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
Table Major Manufacturers of Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
Figure Product Picture of Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
Table Major Manufacturers of Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
Table Sulphonamides Consumption Market Share by Application in 2015
Figure Skin Infections Examples
Figure Gastro Intestinal Tract (GIT) Infection Examples
Figure Meningitis Examples
Figure China Sulphonamides Revenue (Million USD) and Growth Rate (2012-2022)
Table China Sulphonamides Capacity of Key Manufacturers (2015 and 2016)
Table China Sulphonamides Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Sulphonamides Capacity of Key Manufacturers in 2015
Figure China Sulphonamides Capacity of Key Manufacturers in 2016
Table China Sulphonamides Production of Key Manufacturers (2015 and 2016)
Table China Sulphonamides Production Share by Manufacturers (2015 and 2016)
Figure 2015 Sulphonamides Production Share by Manufacturers
Figure 2016 Sulphonamides Production Share by Manufacturers
Table China Sulphonamides Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Sulphonamides Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Sulphonamides Revenue Share by Manufacturers
Table 2016 China Sulphonamides Revenue Share by Manufacturers
Table China Market Sulphonamides Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Sulphonamides Average Price of Key Manufacturers in 2015
Table Manufacturers Sulphonamides Manufacturing Base Distribution and Sales Area
Table Manufacturers Sulphonamides Product Type
Figure Sulphonamides Market Share of Top 3 Manufacturers
Figure Sulphonamides Market Share of Top 5 Manufacturers
Table Abbott Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Laboratories Sulphonamides Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Abbott Laboratories Sulphonamides Market Share (2012-2017)
Table Boehringer Ingelheim Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Pharmaceuticals Sulphonamides Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Pharmaceuticals Sulphonamides Market Share (2012-2017)
Table Bayer AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer AG Sulphonamides Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer AG Sulphonamides Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Sulphonamides Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Sulphonamides Market Share (2012-2017)
Table King Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table King Pharmaceuticals Sulphonamides Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure King Pharmaceuticals Sulphonamides Market Share (2012-2017)
Table Mylan Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mylan Pharmaceuticals Sulphonamides Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Mylan Pharmaceuticals Sulphonamides Market Share (2012-2017)
Table Novartis International AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis International AG Sulphonamides Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis International AG Sulphonamides Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Sulphonamides Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Sulphonamides Market Share (2012-2017)
Table Par Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Par Pharmaceutical Sulphonamides Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Par Pharmaceutical Sulphonamides Market Share (2012-2017)
Table Roche Holding AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Holding AG Sulphonamides Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Holding AG Sulphonamides Market Share (2012-2017)
Table Sanofi Aventis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Stiefel Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Figure China Sulphonamides Capacity, Production and Growth (2012-2017)
Figure China Sulphonamides Revenue (Million USD) and Growth (2012-2017)
Table China Sulphonamides Production, Consumption, Export and Import (2012-2017)
Table China Sulphonamides Production by Type (2012-2017)
Table China Sulphonamides Production Share by Type (2012-2017)
Figure Production Market Share of Sulphonamides by Type (2012-2017)
Figure 2015 Production Market Share of Sulphonamides by Type
Table China Sulphonamides Revenue by Type (2012-2017)
Table China Sulphonamides Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Sulphonamides by Type (2012-2017)
Figure 2015 Revenue Market Share of Sulphonamides by Type
Table China Sulphonamides Price by Type (2012-2017)
Figure China Sulphonamides Production Growth by Type (2012-2017)
Table China Sulphonamides Consumption by Application (2012-2017)
Table China Sulphonamides Consumption Market Share by Application (2012-2017)
Figure China Sulphonamides Consumption Market Share by Application in 2015
Table China Sulphonamides Consumption Growth Rate by Application (2012-2017)
Figure China Sulphonamides Consumption Growth Rate by Application (2012-2017)
Table China Sulphonamides Production by Regions (Provinces)(2012-2017)
Table China Sulphonamides Production Market Share by Regions (Provinces)(2012-2017)
Table China Sulphonamides Production Value by Regions (Provinces)(2012-2017)
Table China Sulphonamides Production Value Market Share by Regions (Provinces)(2012-2017)
Table China Sulphonamides Sales Price by Regions (Provinces)(2012-2017)
Table China Sulphonamides Consumption by Regions (Provinces)(2012-2017)
Table China Sulphonamides Consumption Market Share by Regions (Provinces)(2012-2017)
Table China Sulphonamides Production, Consumption, Export and Import (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sulphonamides
Figure Manufacturing Process Analysis of Sulphonamides
Figure Sulphonamides Industrial Chain Analysis
Table Raw Materials Sources of Sulphonamides Major Manufacturers in 2015
Table Major Buyers of Sulphonamides
Table Distributors/Traders List
Figure China Sulphonamides Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Sulphonamides Revenue and Growth Rate Forecast (2017-2022)
Table China Sulphonamides Production, Import, Export and Consumption Forecast (2017-2022)
Table China Sulphonamides Production Forecast by Type (2017-2022)
Table China Sulphonamides Consumption Forecast by Application (2017-2022)
Table China Sulphonamides Production Forecast by Regions (Provinces)(2017-2022)
Table China Sulphonamides Consumption Forecast by Regions (Provinces)(2017-2022)
Table China Sulphonamides Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...